Valued at USD 416.73 million in 2022, the Nausea Relief Chews Market is projected to reach USD 444.27 million in 2023 and USD 841.40 million by 2032, growing at a CAGR of 7.4% during the forecast period 2023–2032. The report segments the market by indication, distribution channel and region. Competitors include Prestige Consumer Healthcare Inc., Sanofi, Cipla, Pepto Bismol, Emetrol...